PUBLISHER: Grand View Research | PRODUCT CODE: 2112231
PUBLISHER: Grand View Research | PRODUCT CODE: 2112231
The global breast lesion localization methods market size was valued at USD 1.2 billion in 2025 and is projected to grow from USD 1.3 billion in 2026 to USD 2.2 billion by 2033, at a CAGR of 7.3% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 39.4% in 2025. The growth of the global breast lesion localization methods market is driven by the increasing incidence of breast cancer, rising adoption of breast-conserving surgery, technological advancements in localization techniques, and expanding access to early breast cancer diagnosis worldwide.
In addition, the market is driven by a growing shift toward wire-free breast lesion localization technologies, as healthcare providers seek solutions that improve surgical precision, patient comfort, and clinical efficiency. Unlike conventional wire-guided localization, wire-free systems allow localization markers to be placed before the day of surgery, reducing scheduling constraints and enhancing coordination between radiology and surgical teams. These technologies also eliminate external wires, improving patient experience while supporting accurate localization of non-palpable breast lesions. Continuous adoption by hospitals and breast care centers reflects increasing confidence in these advanced systems.
For instance, in July 2026, PIH Health Whittier Hospital became the first hospital in Los Angeles County and Orange County to transition to SCOUT MD wire-free localization technology. The advanced radar-based platform was introduced to improve surgical planning, increase localization precision, streamline clinical workflows, and enhance patient care by eliminating the need for traditional wire-guided localization procedures. This growing transition toward wire-free technologies is expected to support sustained market growth over the forecast period.
"PIH Health is committed to bringing the latest proven technologies to our patients and physicians," said James R. West, president and chief executive officer of PIH Health. "Becoming the first hospital in Los Angeles County and Orange County to transition to SCOUT MD reflects our continued investment in advanced, patient-centered care and our dedication to improving outcomes through innovation."
"SCOUT MD is a huge step in the surgical treatment of patients who are interested in breast conserving surgery," said Rashi Singh MD, breast surgeon at PIH Health Whittier Hospital. "This technology helps surgeons more accurately localize multiple lesions even within the same breast, while supporting a smoother experience for patients throughout their surgical process."
The infographic underscores the significant global burden of breast cancer, with approximately 2.43 million new cases, 693,660 deaths, and 8.15 million five-year prevalent cases reported in 2024. This growing patient population is directly increasing the demand for accurate breast lesion localization methods, particularly for non-palpable lesions detected through mammography, ultrasound, and MRI screening. As breast cancer screening programs expand and early-stage diagnoses become more common, healthcare providers are adopting advanced localization technologies such as magnetic seed, radar-based, RFID, and radioisotope-free systems to improve surgical precision and patient outcomes. Regions with the highest incidence and prevalence, including Asia, Europe, and North America, are expected to remain key markets for breast lesion localization methods due to rising breast-conserving surgeries, expanding screening infrastructure, and the increasing preference for minimally invasive, wire-free localization techniques.
Global Breast Lesion Localization Methods Market Report Segmentation
This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global breast lesion localization methods market report based on type, imaging guidance modality, lesion type, procedure setting, end use, and region: